Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation, March 5, 2009 - Anascorp


Submission Type: Original Application   Submission ID:  125335/0   Office: OBRR  
Centruroides (Scorpion) Immune F(ab)2 Intravenous (Equine)
Instituto Bioclon, S.A. de C.V.          
Telecon Date/Time:  05-MAR-2009 12:00 AM              Initiated by FDA?  Yes
Telephone Number:    
Communication Categorie(s):
Information Request
Telecon Summary:
FDA Participants:   Debbie Cordaro
Non-FDA Participants:    --(b)(4)--
Trans-BLA Group: No
Related STNs:  None
Related PMCs:  None
Telecon Body:

The firm was called on March 5, 2009 seeking clarification of a statement submitted in the January 21, 2009 BLA. Following the pre-BLA meeting to discuss clinical issues, Bioclon provided minutes stating that when the BLA is submitted they intend to respond to disagreements with FDA’s comments for points 1, 3, 5 and 8 from that meeting.
The firm was asked were in the BLA these clarifications can be found.

Page Last Updated: 03/25/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English